Ident. | Authors (with country if any) | Title |
---|
000914 |
Annie Lannuzel [France] ; G. U. Höglinger [Allemagne] ; S. Verhaeghe [France] ; L. Gire [France] ; S. Belson [France] ; M. Escobar-Khondiker [France] ; P. Poullain [France] ; W. H. Oertel [Allemagne] ; E. C. Hirsch [France] ; B. Dubois [France] ; M. Ruberg [France] | Atypical parkinsonism in Guadeloupe : a common risk factor for two closely related phenotypes? |
000D38 |
A. Lannuzel [France] ; P. P. Michel [France] ; G. U. Höglinger [France] ; P. Champy [France] ; A. Jousset [France] ; F. Medja [France] ; A. Lombes [France] ; F. Darios [France] ; C. Gleye [France] ; A. Laurens [France] ; R. Hocquemiller [France] ; E. C. Hirsch [France] ; M. Ruberg [France] | The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism |
000D55 |
E. C. Hirsch [France] ; G. Orieux [France] ; M.-P. Muriel [France] ; C. Francois [France] ; J. Feger [France] | Nondopaminergic neurons in Parkinson's disease |
000D59 |
Stephane Hunot [France] ; E. C. Hirsch [France] | Neuroinflammatory processes in Parkinson's disease. Discussion |
000E95 |
T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France] | Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease |
000F39 |
A. Hartmann [France] ; A. Mouatt-Prigent [France] ; B. A. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France] | FADD: A link between TNF family receptors and caspases in Parkinson's disease |
001155 |
P. Damier [France] ; L. Tramblay [France] ; J. Feger [France] ; E. C. Hirsch [France] | Développement des dyskinésies provoquées par le traitement de la maladie de Parkinson : rôle de la première exposition à la L-DOPA (ou phénomène du « priming ») |
001185 |
N. Kubis [France] ; B. A. Faucheux [France] ; G. Ransmayr [Autriche] ; P. Damier [France] ; C. Duyckaerts [France] ; D. Henin [France] ; B. Forette [France] ; Y. Le Charpentier [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Preservation of midbrain catecholaminergic neurons in very old human subjects |
001189 |
E. C. Hirsch [France] ; BENABID ; OLANOW ; SEALFON ; HALLETT ; LANGSTON ; CALABRESI | Nigrostriatal system plasticity in Parkinson's disease : Effect of dopaminergic denervation and treatment. Discussion |
001195 |
G. Orieux [France] ; C. Francois [France] ; J. Feger [France] ; J. Yelnik [France] ; M. Vila [France] ; M. Ruberg [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease |
001204 |
C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France] | Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion |
001212 |
E. C. Hirsch [France] | Glial cells and Parkinson's disease |
001214 |
C. Perier [France] ; M. Vila [France] ; J. Feger [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats |
001235 |
W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France] | Cloning of rat parkin cDNA and distribution of parkin in rat brain |
001245 |
G. Ransmayr [Autriche] ; B. Faucheux [France] ; C. Nowakowski [Autriche] ; N. Kubis [France] ; S. Federspiel [Autriche] ; W. Kaufmann [Autriche] ; D. Henin [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Age-related changes of neuronal counts in the human pedunculopontine nucleus |
001294 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease |
001295 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry |
001302 |
M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France] | Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia |
001325 |
M.-P. Muriel [France] ; V. Bernard [France] ; A. I. Levey [États-Unis] ; O. Laribi [France] ; D. N. Abrous [France] ; Yves Agid [France] ; B. Bloch [France] ; E. C. Hirsch [France] | Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease |
001358 |
B. A. Faucheux [France] ; A.-M. Bonnet [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Blood vessels change in the mesencephalon of patients with Parkinson's disease |
001395 |
B. A. Faucheux [France] ; E. C. Hirsch [France] | Homéostasie du fer et maladie de Parkinson |
001409 |
J. Villares [France, Brésil] ; B. Faucheux [France] ; M. T. Herrero [Espagne] ; J. A. Obeso [Espagne] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys |
001441 |
E. C. Hirsch [France] ; B. A. Faucheux [France] | Iron metabolism and Parkinson's disease |
001447 |
E. C. Hirsch [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] | Glial cells and inflammation in Parkinson's disease : A role in neurodegeneration? |
001547 |
B. A. Faucheux [France] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease |
001554 |
R. Levy [France] ; L.-N. Hazrati [Canada] ; M.-T. Herrero [France, Espagne] ; M. Vila [France] ; O.-K. Hassani [France] ; M. Mouroux [France] ; M. Ruberg [France] ; H. Asensi [Espagne] ; Yves Agid [France] ; J. Feger [France] ; J. A. Obeso [Espagne] ; A. Parent [Canada] ; E. C. Hirsch [France] | Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states |
001561 |
E. C. Hirsch [France] ; M. T. Herrero [Espagne] | Neurochemical correlates of parkinsonism: Role of dopaminergic lesions |
001640 |
S. Hunot [France] ; F. Boissiere [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Nitric oxide synthase and neuronal vulnerability in Parkinson's disease |
001644 |
M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. Hirsch | Metabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study |
001648 |
A. Mouatt-Prigent [France] ; J. O. Karlsson ; Yves Agid [France] ; E. C. Hirsch [France] | Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon : A role in nerve cell death ? |
001652 |
S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissiere [France] ; E. Leguern [France] ; C. Brana [France] ; P. P. Gautris [France] ; J. Guerin [France] ; B. Bloch [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain : a post mortem in situ hybridization study with special reference to Parkinson's disease |
001654 |
M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni] | Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys |
001658 |
P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ? |
001661 |
M. Vila [France] ; M. T. Herrero ; R. Levy [France] ; B. Faucheux [France] ; M. Ruberg [France] ; J. Guillen ; M. R. Luquin ; J. Guridi ; F. Javoy-Agid [France] ; Yves Agid [France] ; J. A. Obeso ; E. C. Hirsch [France] | Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes |
001667 |
B. Leveugle [États-Unis] ; B. A. Faucheux [France] ; C. Bouras ; N. Nillesse [France] ; G. Spik [France] ; E. C. Hirsch [France] ; Y. Agig [France] ; P. R. Hof [États-Unis] | Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases |
001704 |
R. Levy [France] ; M. Vila [France] ; M.-T. Herrero ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease |
001708 |
F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazine |
001712 |
P. Anglade [France] ; S. Tsuji [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease |
001729 |
M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson | Effects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum |
001739 |
B. A. Faucheux [France] ; M. T. Herrero ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Autoradiographic localization and density of[125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys |
001794 |
S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France] | Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography |
001796 |
J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. Hirsch | Loss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease |
001800 |
G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease |
001805 |
A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch | Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease ? |
001808 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
001856 |
A. Kastner [France] ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease |
001871 |
O. Strada [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] | Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease |
001876 |
A. Kastner [France] ; E. C. Hirsch ; M. T. Herrero ; F. Javoy-Agid ; Yves Agid [France] | Immunocytochemical quantification of tyrosine hydroxylase at a cellular level in the mesencephalon of control subjects and patients with Parkinson's and Alzheimer's disease |
001877 |
P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-Agid | Glutathione peroxidase, glial cells and Parkinson's disease |
001878 |
M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France] | Gangliosides and parkinsonism |
001879 |
M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del Rio | GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys |
001887 |
E. C. Hirsch [France] | Does oxidative stress participate in nerve cell death in Parkinson's disease ? |
001888 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ? |
001889 |
B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France] | Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease |
001890 |
M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum |
001895 |
J. Villares [France] ; B. Faucheux ; O. Strada ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-Agid | Autoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem |
001954 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
001958 |
E. C. Hirsch [France] ; A. Mouatt ; B. Faucheux ; A.-M. Bonnet ; F. Javoy-Agid ; A. M. Graybiel ; Yves Agid [France] | Dopamine, tremor, and Parkison's disease |
001A09 |
E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France] | Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis |
001A56 |
E. C. Hirsch ; C. Duyckaerts ; F. Javoy-Agid ; J.-J. Hauw ; Yves Agid [France] | Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease ? |
001A57 |
F. Javoy-Agid ; E. C. Hirsch ; S. Dumas ; C. Duyckaerts ; J. Mallet ; Yves Agid [France] | Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease : an in situ hybridization study |
001A61 |
S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France] | Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration |
001A95 |
E. C. Hirsch ; A. M. Graybiel ; Yves Agid [France] | Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease |
001B56 |
E. C. Hirsch ; A. M. Graybiel ; C. Duyckaerts ; F. Javoy-Agid | Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy |